Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
CHINA OILFIELD
02883
5
CNOOC
00883
| (FY)Dec 31, 2025 | (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | |
|---|---|---|---|---|---|---|---|---|---|
| Turnover | -17.66%83.87M | -36.51%35.68M | -19.54%101.86M | --56.2M | 12.38%126.6M | ---- | 31.09%112.65M | ---- | --85.93M |
| Operating income | -17.66%83.87M | -36.51%35.68M | -19.54%101.86M | 56.2M | 12.38%126.6M | 31.09%112.65M | 85.93M | ||
| Cost of sales | 10.54%-63.1M | 36.52%-26.29M | 25.64%-70.53M | ---41.42M | -15.66%-94.85M | ---- | -31.72%-82.01M | ---- | ---62.26M |
| Operating expenses | 10.54%-63.1M | 36.52%-26.29M | 25.64%-70.53M | -41.42M | -15.66%-94.85M | -31.72%-82.01M | -62.26M | ||
| Gross profit | -33.69%20.77M | -36.47%9.39M | -1.31%31.33M | 14.78M | 3.61%31.74M | 29.41%30.64M | 23.68M | ||
| Selling expenses | 43.39%-8.75M | 59.79%-4.12M | 25.19%-15.46M | ---10.25M | -7.33%-20.67M | ---- | -27.32%-19.26M | ---- | ---15.13M |
| Administrative expenses | 3.83%-113.04M | -481.56%-66.87M | -351.93%-117.54M | ---11.5M | -7.44%-26.01M | ---- | -16.69%-24.21M | ---- | ---20.75M |
| Revaluation surplus | 194.19%79.02M | --31.63M | ---83.9M | ---- | ---- | ---- | ---- | ---- | ---- |
| -Changes in the fair value of financial assets | 194.19%79.02M | --31.63M | ---83.9M | ---- | ---- | ---- | ---- | ---- | ---- |
| Impairment and provision | -36,222.62%-30.51M | ---13K | -4,300.00%-84K | ---- | --2K | ---- | ---- | ---- | ---- |
| -Goodwill impairment | ---27.63M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| -Other impairment is provision | -3,334.52%-2.89M | ---13K | -4,300.00%-84K | ---- | --2K | ---- | ---- | ---- | ---- |
| Special items of operating profit | 102.46%2.03M | -7.61%1.25M | -5,750.82%-82.56M | 101.76%1.35M | -285.52%-1.41M | -3,763.49%-76.9M | -182.81%-366K | ---1.99M | --442K |
| Operating profit | 81.18%-50.48M | -411.99%-28.73M | -1,541.23%-268.21M | 92.70%-5.61M | -23.88%-16.34M | -3,763.49%-76.9M | -12.25%-13.19M | -1.99M | -11.75M |
| Financing cost | 44.12%-964K | 90.95%-80K | -4.04%-1.73M | ---884K | -191.90%-1.66M | ---- | -816.13%-568K | ---- | ---62K |
| Special items of earning before tax | ---- | ---- | ---- | ---- | ---- | ---4.26M | ---- | ---- | ---- |
| Earning before tax | 80.94%-51.44M | -343.54%-28.81M | -1,399.64%-269.94M | 92.00%-6.5M | -30.81%-18M | -3,977.40%-81.15M | -16.47%-13.76M | -1.99M | -11.81M |
| Tax | -130.36%-51K | -113.31%-39K | -75.65%168K | --293K | 9.00%690K | ---- | -21.07%633K | ---- | --802K |
| After-tax profit from continuing operations | 80.91%-51.49M | -365.12%-28.85M | -1,458.45%-269.77M | 92.36%-6.2M | -31.87%-17.31M | -3,977.40%-81.15M | -19.21%-13.13M | -1.99M | -11.01M |
| Earning after tax | 80.91%-51.49M | -365.12%-28.85M | -1,458.45%-269.77M | 92.36%-6.2M | -31.87%-17.31M | -3,977.40%-81.15M | -19.21%-13.13M | -1.99M | -11.01M |
| Minority profit | ---- | ---- | ---- | ---- | ---- | ---- | -325.00%-9K | ---- | --4K |
| Profit attributable to shareholders | 80.91%-51.49M | -365.12%-28.85M | -1,458.45%-269.77M | 92.36%-6.2M | -31.96%-17.31M | -3,977.40%-81.15M | -19.08%-13.12M | -1.99M | -11.02M |
| Basic earnings per share | 81.43%-0.1153 | -681.93%-0.0649 | -2,575.86%-0.6208 | 99.74%-0.0083 | -31.82%-0.0232 | -110.39%-3.24 | -18.92%-0.0176 | -1.54 | -0.0148 |
| Diluted earnings per share | -110.39%-3.24 | -18.92%-0.0176 | -1.54 | -0.0148 | |||||
| Currency Unit | SGD | SGD | SGD | SGD | SGD | HKD | SGD | HKD | SGD |
| Accounting Standards | IAS | IAS | IAS | IAS | IAS | HKAS | IAS | HKAS | IAS |
| Audit Opinions | -- | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- | Unqualified Opinion |
| Auditor | -- | -- | Deloitte Touche Tohmatsu会计师事务所 | -- | KPMG | -- | KPMG | -- | KPMG |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.